STRS Ohio’s Voyager Therapeutics VYGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-38,000
Closed -$147K 2340
2026
Q1
$147K Hold
38,000
﹤0.01% 1622
2025
Q4
$149K Sell
38,000
-12,700
-25% -$56.2K ﹤0.01% 1662
2025
Q3
$237K Hold
50,700
﹤0.01% 1454
2025
Q2
$158K Sell
50,700
-25,100
-33% -$81K ﹤0.01% 1738
2025
Q1
$256K Buy
75,800
+6,000
+9% +$28K ﹤0.01% 1445
2024
Q4
$396K Hold
69,800
﹤0.01% 1291
2024
Q3
$408K Buy
69,800
+8,700
+14% +$63.3K ﹤0.01% 1343
2024
Q2
$483K Buy
61,100
+28,000
+85% +$235K ﹤0.01% 1275
2024
Q1
$308K Buy
33,100
+14,500
+78% +$122K ﹤0.01% 1425
2023
Q4
$156K Hold
18,600
﹤0.01% 1628
2023
Q3
$144K Sell
18,600
-10,700
-37% -$97.7K ﹤0.01% 1652
2023
Q2
$335K Buy
+29,300
New +$303K ﹤0.01% 1441
2021
Q2
Sell
-133,200
Closed -$627K 2439
2021
Q1
$627K Buy
133,200
+55,900
+72% +$381K ﹤0.01% 1474
2020
Q4
$552K Buy
77,300
+38,600
+100% +$371K ﹤0.01% 1423
2020
Q3
$412K Hold
38,700
﹤0.01% 1435
2020
Q2
$488K Sell
38,700
-6,700
-15% -$77.9K ﹤0.01% 1326
2020
Q1
$415K Hold
45,400
﹤0.01% 1271
2019
Q4
$633K Buy
45,400
+9,500
+26% +$138K ﹤0.01% 1278
2019
Q3
$617K Buy
35,900
+14,800
+70% +$311K ﹤0.01% 1094
2019
Q2
$574K Buy
+21,100
New +$483K ﹤0.01% 1209
2017
Q1
Sell
-5,900
Closed -$71.6K 1935
2016
Q4
$75K Sell
5,900
-5,700
-49% -$73.2K ﹤0.01% 1716
2016
Q3
$139K Sell
11,600
-400
-3% -$5.42K ﹤0.01% 1616
2016
Q2
$131K Buy
12,000
+10,100
+532% +$124K ﹤0.01% 1649
2016
Q1
$16K Hold
1,900
﹤0.01% 1833
2015
Q4
$41K Buy
+1,900
New +$43.8K ﹤0.01% 1807

Other funds holding VYGR

STRS Ohio's VYGR Position: Q2 2026 in Review

STRS Ohio sold out of Voyager Therapeutics (VYGR) in Q2 2026, closing a stake of 38,000 shares — an estimated $147K sold.

STRS Ohio first reported a position in VYGR in Q4 2015 and held it in 25 quarters. The position peaked at $633K in Q4 2019. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • STRS Ohio reported no remaining Voyager Therapeutics position as of Q2 2026 after selling out during the quarter.
  • STRS Ohio sold 38,000 Voyager Therapeutics shares in Q2 2026, an estimated $147K.
  • STRS Ohio first reported a position in Voyager Therapeutics in Q4 2015 and held it in 25 quarters.
  • STRS Ohio's Voyager Therapeutics position peaked at $633K in Q4 2019.
  • 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.